Chicago Partners Investment Group LLC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 95 filers reported holding AKERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Chicago Partners Investment Group LLC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$304,416
-73.1%
25,2000.0%0.02%
-72.9%
Q2 2023$1,133,244
-4.3%
25,200
-4.3%
0.06%
-14.5%
Q1 2023$1,184,516
+0.4%
26,346
+1.4%
0.07%
-4.2%
Q4 2022$1,179,868
+2.3%
25,994
-13.9%
0.07%
-12.2%
Q3 2022$1,153,000
+273.1%
30,2000.0%0.08%
+272.7%
Q2 2022$309,000
+17.0%
30,2000.0%0.02%
+10.0%
Q1 2022$264,000
-51.8%
30,2000.0%0.02%
-48.7%
Q4 2021$548,000
-26.8%
30,2000.0%0.04%
-26.4%
Q3 2021$749,000
-43.0%
30,200
-50.0%
0.05%
+8.2%
Q2 2021$1,314,000
+44.1%
60,400
+100.0%
0.05%
-34.7%
Q1 2021$912,000
-2.8%
30,2000.0%0.08%
-15.7%
Q4 2020$938,000
+12.6%
30,2000.0%0.09%
-10.1%
Q3 2020$833,000
-27.6%
30,2000.0%0.10%
-31.2%
Q2 2020$1,150,000
+85.2%
30,2000.0%0.14%
+50.0%
Q1 2020$621,000
+4.4%
30,2000.0%0.10%
+31.5%
Q4 2019$595,000
-6.4%
30,2000.0%0.07%
-18.9%
Q3 2019$636,000
-5.9%
30,2000.0%0.09%
-7.2%
Q2 2019$676,00030,2000.10%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders